|
ecology, molecular virology, pathogenesis, sarscov-2 |
19 |
|
antivirals, biobank, covid-19, immunity, pathogenesis, viral characteristics |
17 |
|
antiviral, diagnostics, emerging, infections, pathogenesis, vaccine |
14 |
|
animal, coronavirus, covid-19, hamster, model |
5 |
|
antiviral treatment, drug discovery, drug repurposing |
5 |
|
antiviral, casein kinase 1, coronavirus, mers, phosphoproteomics |
5 |
|
antiviral, casein kinase, phosphoproteomics, virus, zika |
5 |
|
1) coronavirus
2) antiviral
3) fragment-based drug discovery
4) animal models
5) chemical proteomics |
5 |
|
anti-influenza agents, influenza virus rna polymerase |
4 |
|
antibody, antiviral, nanobody, treatment, virus, zika |
4 |
|
combatting, development, infection, inhibitors, novel, sars-cov-2 |
4 |
|
coronavirus, antiviral, fragment-based drug discovery, animal models, chemical proteomics |
4 |
|
coronaviruses, cholesterol, lipid, spike, treatment |
4 |
|
animal models, antiviral therapy, immunopathology, influenza a, mannose metabolism, sars-cov-2 |
3 |
|
antiviral drug, broad-spectrum, fidelity, mutation rate, polioviurs, rna-dependent rna polymerase |
3 |
|
antiviral, broad-spectrum, glycolysis, host-virus interaction, mouse model, pfkfb3 |
3 |
|
antiviral, coronavirus, covid-19, nanobody, sars-cov-2, treatment |
3 |
|
antiviral, covid-19, drug discovery, high throughput screening, rdrp |
3 |
|
antiviral, covid-19, main protease |
3 |
|
broad-spetrum, drug target, emerging human viruses, lipid metabolism, srebps |
3 |
|
coronavirus, covid-19, diacylglycerol acyltransferase, lipidomics, sars-cov-2 |
3 |
|
hepatitis e virus , animal models , molnupiravir, antivirals , |
3 |
|
ace2, covid19, drug design, mutagenesis and screening, protein-protein interaction, sars-cov-2 s protein |
2 |
|
influenza, intranasal delivery, powder aerosol, pulmonary delivery, spray drying, spray freeze drying |
2 |
|
""antiviral"", ""sars-cov-2"", ""combinatorial therapy"", animal model"", immunomodulation"" |
2 |
|
anti-ageing, stem cells, trophoblast, repurposed drug screening, epscs
|
2 |
|
antiviral drug discovery, machine intelligence, web application |
2 |
|
bioinorganic chemistry, bismuth, bioassay, sars-cov-2 , nsp10/nsp14 |
2 |
|
coronaviruses / antiviral therapy / papain-like protease (plpro) / sars-unique domain (sud) / fragment-based drug discovery |
2 |
|
influenza a virus , glycolysis , metabolomics, animal models , sumoylation |
2 |
|
molecular glue, peptide nucleic acid, antigene effect, fluorescence detection, viral infection theranostics |
2 |
|
sars-cov-2, main protease 3clpro/nsp5, zinc-finger antiviral protein, antiviral response, viral antagonism |
2 |
|
antiviral discovery, transcriptional factors, virus-host interaction |
1 |
|
antiviral, cap-binding, flu a, fluorescence polarization, pb2 |
1 |
|
antiviral discovery; medical chemistry; fragment-based screening. |
1 |
|
application research, live attenuated, sars-cov-2 strain |
1 |
|
application research, live, attenuated, sars-cov-2, strain |
1 |
|
mannose, broad-spectrum, metabolic reprogramming |
1 |
|
na |
1 |
|
pfkfb3, glycolytic reprogramming, broad-spectrum, antiviral , animal model |
1 |
|
pyrimidine synthesis pathway, antiviral response, cad enzyme |
1 |
